Neuexcell Therapeutics Inc
NeuExcell Therapeutics Inc. is a pioneering gene therapy company based in Philadelphia, focusing on the restoration of health for patients suffering from neurodegenerative diseases and central nervous system injuries. Founded on Professor Gong Chen's groundbreaking in vivo neural regeneration technology, the company aims to transform treatments for conditions such as Alzheimer's disease, Parkinson's disease, and stroke through its innovative ATN ASTROCYTES TO NEURONSTM platform.
With a skilled leadership team boasting decades of experience in gene therapy and neuroscience, NeuExcell is actively bringing its neuroregeneration technology to clinical application. The company's commitment to advancing its pipeline is evident through its recent clinical trials and significant achievements, including FDA designations for its therapies.
Generated from the website



